Trellus Health plc
TRLHF
$0.015
$0.000.00%
| Weiss Ratings | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Mar 07, 2025 | |||
| Valuation | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.98M | |||
| Enterprise Value | -4.28M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -48.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 50.00 | |||
| Price/Book (Q) | 0.16 | |||
| Enterprise Value/Revenue (TTM) | -81.00 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | 1.01 | |||
| Enterprise Value/EBIT | 1.00 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 161.51M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 866 4165 | |||
| Address | 44 South Broadway White Plains, NY 10601 | |||
| Website | www.trellushealth.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 257.14% | |||
| Earnings Growth (Q YOY) | -9.08% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -9.09% | |||
| Balance Sheet | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.05M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 8.25M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 15.61M | |||
| Current Ratio (Q) | 14.142 | |||
| Book Value Per Share (Q) | $0.10 | |||
| Total Assets (Q) | 16.19M | |||
| Total Current Liabilities (Q) | 583.00K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 583.00K | |||
| Total Common Equity (Q) | 15.61M | |||
| Cash Flow | TRLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
